TIRR Memorial Hermann Spinal Cord Injury and Disability Research Center
Houston, Texas, 77030, United States
NCT Number: NCT06227000
The purpose of this study is to develop a health promotion group intervention to meet the unique health promotion needs of people aging with SCI, to test the efficacy of the adapted intervention program, Living Longer and Stronger with SCI, in a randomized controlled trial and to assess the mechanisms through which the intervention may enhance physical, psychological, and social health.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Study staff will schedule a brief zoom training session with each person assigned to the intervention to ensure that they are able to download and use the Zoom platform. Once a weekly session day and time has been determined the 8-week LLS intervention program will begin. LLS group participants will participate in 2-hour weekly sessions co-facilitated by a study investigator and one of the study's senior advisors. Participants will be encouraged to set a health-oriented goal and complete weekly action plans. They will be provided with materials each week with health-related information and resources. Participants will also be asked to complete a short survey each week to rate the session. After completing the 8 sessions, a link to the post-test survey and some questions to evaluate the LLS program will be sent to the participants. Finally there will be follow up survey to be completed at 4 months post intervention.
Participants will be sent links to the three surveys at the same time as those assigned to the LLS group but they will not attend any of the zoom calls. They will be offered all study materials at the end of the study.
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
a 5-item scale of self-perceived health. The subscale consists of a single-item rating of health and four additional items reflecting perceived current health, resistance to illness and health outlook. Individual item responses range from 1-5. To score, select items (1, 3, and 5) are recoded so that higher scores indicate better health. The 5 items are then summed and transformed to a 0-100 scale with higher scores reflecting better health.
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This consists of one item assessing pain intensity/severity rated on a 11-point scale ranging from 0 (no pain) to 10 (pain so severe you couldn't stand it), higher score indicting worse pain
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This is a 1 item questionnaire that is scored on a linear scale from 0 (no interference)-10 (extreme interference), higher score indicting worse outcome
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This is a 16 item questionnaire and each item scores range from 0 (not experienced or insignificant problem) to 3 (significant or chronic problem). Items are summed with a potential score range of 0-48 with higher scores reflecting more severe secondary health conditions.
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This is an 8 item questionnaire and each is scored from 0(not at all) to 3(nearly every day), for a maximum score of 24 higher score indicating worse outcome
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This is a 2 item questionnaire and each is scored from 0(not at all) to 3(nearly every day), for a maximum score of 6 higher score indicating worse outcome
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This is a 4 item questionnaire and questions 1 and 4 are scored from 0(never) to 4(very often) , and questions 2 and 3 are scored from 0(very often) to 4 (never) for a maximum score of 16 higher score indicating worse outcome
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This is a 10 item questionnaire, and each is scored from from 1 (never) to 5 (always). Items are summed to create a raw score. Raw scores are then converted to an IRT-based T-score using provided look-up tables. T-scores range from 26.7 to 68.6 with higher scores representing more positive affect and well-being.
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This is a 4 item questionnaire and each is scored on a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Scores are summed resulting in a scale score ranging from 4 to 28 with higher scores representing greater life satisfaction.
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This is a 3 item questionnaire and each is scored from 1(hardly ever) to 3(often) for a maximum score of 9 higher score indicating worse outcome
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This is a 10 item questionnaire and each is scored from 1(not at all) to 5(very much ) with the scale direction depending on whether the item is positively or negatively worded. Item scores are summed to create a raw score which is then converted to an IRT-based T-score using look-up tables. T-scores range from 28.3 to 60.5 with higher scores representing more satisfaction with social roles and activities.
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This is a 10 item questionnaire and each is scored from 1(not at all true) to 4(exactly true), for a maximum score of 40 , higher number indicating better outcome
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This is a 6 item questionnaire and each is scored from 1(not at all) to 5(completely) for a maximum score of 30, higher score indicating better outcome
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This is a 52 item questionnaire and each is scored from 1(never) to 4(routinely).Items are summed and divided by 52, resulting in a scale score reflecting the average score across all items. This score can range from 1-4, with higher scores reflecting more engagement in health promoting behaviors and practices.
Time frame: Baseline, end of intervention (8 weeks after baseline), follow up (4 months after end of intervention )
This is a 22 item questionnaire with each health behavior item scored from 0 (never) to 3 (always) for a maximum score of 66, higher score indicating better outcome
The University of Texas Health Science Center, Houston
Other
Living Longer and Stronger With Spinal Cord Injury: An Online Program for Promoting Healthy Aging
Acronym: LLS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06243952
Central Nervous System Diseases, Nervous System Diseases
Lausanne, Canton of Vaud, Switzerland
View Trial DetailsNCT05589415
Central Nervous System Diseases, Nervous System Diseases
Harlingen, Texas, United States
View Trial DetailsNCT05218447
Central Nervous System Diseases, Nervous System Diseases
Dallas, Texas, United States
View Trial DetailsNCT04457206
Central Nervous System Diseases, Nervous System Diseases
St Louis, Missouri, United States
View Trial Details